added 2007 Wed Jan 31 20:59:44 by bhartzer
A blood thinning drug made by GlaxoSmithKline could get a boost Thursday as federal regulators are expected to grant approval for a new use in patients at risk of heart attack.
A blood thinning drug made by GlaxoSmithKline could get a boost Thursday as federal regulators are expected to grant approval for a new use in patients at risk of heart attack.
